Skip to main content
Caplight Logo









Doser

Doser

Private
LeidenHealthcare & Life Scienceshttps://dosermedical.com

Last Round

Grant

Mar 27, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Doser operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Grant round in March 2023.

Doser is a health tech company that develops advanced technological tools, including a 3D printer, enabling pharmacists to create personalized medication.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Precision Medicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Doser Comparables

Compare Doser with similar companies based on industry and business-model similarity.

Doser comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MB Therapeutics
91%
FabRx
91%
CurifyLabs
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Doser Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 27, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Niels Ouwerkerk

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Doser Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 84% MoM.

  • Jul 28, 2026

    Monthly visitors grew 141% MoM, reaching 2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Doser Filings

Explore SEC and related filing metadata, where available.

Doser filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Doser's valuation, stock price, and market status.

Is Doser a public or private company?

Doser is a private company.

What is the current stock price of Doser?

Doser is a private company, so its shares have no public market price. Caplight tracks Doser's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Doser worth (valuation)?

Valuation information for Doser is not publicly available.

Can I buy Doser stock?

Doser shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Doser's last funding round?

Doser's most recent funding round was Grant on March 27, 2023.

Who are the main investors in Doser?

Key investors in Doser include unlock_, Libertatis Ergo Holding, Netherlands Organization for Scientific Research, European Union, Provincie Zuid-Holland.

Will Doser IPO soon?

No public IPO plans have been announced for Doser.

How can I track Doser secondary market activity?

Caplight tracks bids, offers, and trades in Doser's shares on secondary markets.

Firmographic Details

HeadquartersLeiden
Employee Range10
Year Founded2019
Last FundingMar 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?